Biofrontera Inc.
BFRI
$1.54
-$0.02-1.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -604.00K | -4.75M | 5.64M | -6.65M | -5.32M |
| Total Depreciation and Amortization | 196.00K | 187.00K | 220.00K | 207.00K | 222.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 393.00K | 691.00K | -778.00K | 664.00K | 141.00K |
| Change in Net Operating Assets | -1.64M | 3.80M | -7.46M | 1.96M | 1.92M |
| Cash from Operations | -1.66M | -70.00K | -2.38M | -3.82M | -3.05M |
| Capital Expenditure | 0.00 | -5.00K | 1.00K | 1.00K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 3.00M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -5.00K | 3.00M | 1.00K | -1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 2.35M | 8.50M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -8.50M | 8.50M |
| Cash from Financing | -- | -- | 2.35M | 0.00 | 8.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.66M | -75.00K | 2.98M | -3.82M | 5.45M |